Dear Doctor Letter (Rote-Hand-Brief) on medicinal products containing tetrazepam (e.g. Musaril®): Ruling of suspension due to rare, serious skin reactions
2013.06.25
Active substance: tetrazepam
The company Sanofi-Aventis Deutschland GmbH is sending out information that the marketing authorisations for medicinal products containing tetrazepam (e.g. Musaril®) have been suspended in the EU.
To the graduated plan procedure (available in German only)
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN